BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 16467608)

  • 1. [Use of strontium-89 in the analgesic treatment of cancer patients with bone metastases].
    Baranauskas Z; Valuckas K; Aleknavicius E; Jankevicius F; Burneckis A; Paviloniene I
    Medicina (Kaunas); 2006; 42(1):11-4. PubMed ID: 16467608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strontium-89 for palliation of pain from bone metastases in patients with prostate and breast cancer.
    Pons F; Herranz R; Garcia A; Vidal-Sicart S; Conill C; Grau JJ; Alcover J; Fuster D; Setoain J
    Eur J Nucl Med; 1997 Oct; 24(10):1210-4. PubMed ID: 9323260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strontium 89 therapy for the palliation of pain due to osseous metastases.
    Robinson RG; Preston DF; Schiefelbein M; Baxter KG
    JAMA; 1995 Aug; 274(5):420-4. PubMed ID: 7542352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic radionuclide therapy in pain palliation.
    Liepe K; Runge R; Kotzerke J
    Am J Hosp Palliat Care; 2005; 22(6):457-64. PubMed ID: 16323716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [89Sr Therapy for pain relief in patients with bone metastases].
    Koizumi K; Arbab AS; Toyama K; Shirasu M; Osawa S; Araki T; Yamaguchi M; Onishi H; Araki T; Arai T; Komatsu H; Ueno A; Nokata H
    Kaku Igaku; 1996 Nov; 33(11):1243-8. PubMed ID: 8986064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone pain palliation with 85Sr therapy.
    Giammarile F; Mognetti T; Blondet C; Desuzinges C; Chauvot P
    J Nucl Med; 1999 Apr; 40(4):585-90. PubMed ID: 10210217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of strontium 89 for palliation of pain from bone metastases associated with hormone-refractory prostate cancer.
    Crawford ED; Kozlowski JM; Debruyne FM; Fair WR; Logothetis CJ; Balmer C; Robinson RG; Porter AT; Kirk D
    Urology; 1994 Oct; 44(4):481-5. PubMed ID: 7524233
    [No Abstract]   [Full Text] [Related]  

  • 8. The correlation between palliation of bone pain by intravenous strontium-89 and external beam radiation to linked field in patients with osteoblastic bone metastases.
    Ron IG; Stav O; Vishne T; Evan-Sapir E; Soyfer V; Agai R; Cherny N; Kovner F
    Am J Clin Oncol; 2004 Oct; 27(5):500-4. PubMed ID: 15596920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone pain palliation with strontium-89 in breast cancer patients with bone metastases and refractory bone pain.
    Berna L; Carrio I; Alonso C; Ferré J; Estorch M; Torres G
    Eur J Nucl Med; 1995 Oct; 22(10):1101-4. PubMed ID: 8542891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treating symptomatic osseous metastases from prostate cancer.
    Soffen EM; Greenberg AS; Baumann JC
    N J Med; 1997 Nov; 94(11):33-7. PubMed ID: 9385818
    [No Abstract]   [Full Text] [Related]  

  • 11. Strontium-89: treatment results and kinetics in patients with painful metastatic prostate and breast cancer in bone.
    Robinson RG; Blake GM; Preston DF; McEwan AJ; Spicer JA; Martin NL; Wegst AV; Ackery DM
    Radiographics; 1989 Mar; 9(2):271-81. PubMed ID: 2467331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strontium-89 chloride in the treatment of bone metastases from breast cancer.
    Baziotis N; Yakoumakis E; Zissimopoulos A; Geronicola-Trapali X; Malamitsi J; Proukakis C
    Oncology; 1998; 55(5):377-81. PubMed ID: 9732212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strontium-89 chloride (Metastron) for palliative treatment of bony metastases. The University of Minnesota experience.
    Lee CK; Aeppli DM; Unger J; Boudreau RJ; Levitt SH
    Am J Clin Oncol; 1996 Apr; 19(2):102-7. PubMed ID: 8610630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pain palliation and nuclear medicine.
    McEwan AJ
    Eur J Nucl Med; 1993 Jan; 20(1):1-3. PubMed ID: 7678395
    [No Abstract]   [Full Text] [Related]  

  • 15. Disseminated intravascular coagulation in a patient treated with strontium-89 for metastatic carcinoma of the prostate.
    Paszkowski AL; Hewitt DJ; Taylor A
    Clin Nucl Med; 1999 Nov; 24(11):852-4. PubMed ID: 10551466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 89Sr versus 153Sm-EDTMP: comparison of treatment efficacy of painful bone metastases in prostate and breast carcinoma.
    Baczyk M; Czepczyński R; Milecki P; Pisarek M; Oleksa R; Sowiński J
    Nucl Med Commun; 2007 Apr; 28(4):245-50. PubMed ID: 17325585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The treatment of painful osteoblastic metastases: what can we expect from nuclear oncology?
    Silberstein EB
    J Nucl Med; 1994 Dec; 35(12):1994-5. PubMed ID: 7527457
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of repeated strontium-89 chloride therapy on bone pain palliation in patients with skeletal cancer metastases.
    Kasalický J; Krajská V
    Eur J Nucl Med; 1998 Oct; 25(10):1362-7. PubMed ID: 9818274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone pain palliation with strontium-89 in cancer patients with bone metastases.
    Giammarile F; Mognetti T; Resche I
    Q J Nucl Med; 2001 Mar; 45(1):78-83. PubMed ID: 11456379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicentre observational study of radionuclide therapy in patients with painful bone metastases of prostate cancer.
    Dafermou A; Colamussi P; Giganti M; Cittanti C; Bestagno M; Piffanelli A
    Eur J Nucl Med; 2001 Jul; 28(7):788-98. PubMed ID: 11504074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.